#ghrh

[lanternlightss]

everyone think about dahlibard today

[ninthform]

“my mum likes you she calls you the sexy vicar” “oh well tell her i say thanks for me” girl i’m sobbing you can’t just throw that in there

[luv3deluxe]

jag.hauhr

[nickelsonwooster]

The closely monitored and tailored use of hormones and peptides coupled with fitness and nutrition is the most potent one-two punch for aging well.  Dr. Mike Carragher @carraghermethod and I have been on this journey for almost 14 years together. #peptides #hormones #drmikecarragher #virtualmedicine #hgh #testosterone #humangrowthhormone #ghrh #ghrp https://www.instagram.com/p/CdqusqGLJNd/?igshid=NGJjMDIxMWI=

[dominicvail]

Actually, i think the differences between Eric and Nell’s responses to post shooting trauma are important, because Nell’s response to killing a man was her inability to stop thinking of her victim as a person, and those who know him and love him, it was a reaction based on the behalf of others, but Eric’s response is more self based, he’s shaken not because of the victim, but because he killed him. 

So, Nell wasn’t explicitly bothered by her ability to kill as much as she was suffering from feeling compassion to those who would be hurt by her would be killer’s death, whereas Eric was explicitly bothered by the fact that he acted and killed somebody. 

It’s why i personally think that Nell is suited to field work and Eric isn’t, Nell’s never shown any real self doubt or self disdain towards her ability to kill somebody, whereas that was Eric’s reaction entirely. Eric didn’t like that he killed somebody, it was a self-centered reaction (that sounds judgmental, it’s not, i think most would react the way he does), and i feel like having a reaction of compassion towards others after killing somebody would be easier to work through than it would to work past having a genuine disdain at your own ability to kill, which Eric appears to have. 

Nell is traumatised because a man is dead, Eric is traumatised because he killed a man, big difference. 

[yearpeak]

Expanding the Analytical Portfolio: Structural Stabilization of GHRH Analogs for Metabolic Evaluation. 🔬

We are pleased to announce the formal integration of stabilized Tesamorelin (10mg) into the YearPeak™ research catalog. As independent metabolic and lipolysis frameworks demand higher baseline precision, the structural fidelity of growth hormone-releasing hormone (GHRH) derivatives remains a critical baseline variable.

Tesamorelin is an N-terminally modified analog of human GHRH. This specific alteration (the addition of a trans-3-hexenoic acid moiety) significantly alters its pharmacokinetic profile, extending its enzymatic half-life against dipeptidyl peptidase-4 (DPP-4) cleavage compared to native GHRH sequences. In longitudinal assays, this allows for sustained interaction with pituary GHRH receptors to track downstream pulsatile IGF-1 signaling matrices without inducing immediate tachyphylaxis.

At YearPeak™, our methodologies are governed by graduate biochemistry credentials from the Technical University of Munich (TUM). We eliminate compounding impurities by guaranteeing absolute vacuum desiccation and strict salt-exchange tracking across our entire catalog.

Our verified research chemical pipeline is now allocated for global dispatch:

🧪 YearPeak™ Tesamorelin — 10mg (Stabilized GHRH Analog) 🔗 Catalog Node: https://www.yearpeak.com/products/yearpeak-tesamorelin-10mg-stabilized-ghrh-analog?st=

Complementary Signaling Matrices Available for Combined Protocols: 🧪 YearPeak™ Epithalon (10mg) — [Telomerase/Chronobiology Tracking]: https://www.yearpeak.com/products/yearpeak-epithalon-10mg-aedg-khavinson-tetrapeptide?st= 🧪 YearPeak™ BPC-157 (10mg) — [Angiogenic Tissue Remodeling]: https://www.yearpeak.com/products/yearpeak-bpc-157-10mg-tissue-repair-pentadecapeptide?st=

Apply code PEAKRESEARCH at checkout for an introductory 10% developer credit across all allocations.

[dragonpharma]

CJC-1295 DAC: Understanding Its Role in Growth Hormone Signaling

CJC-1295 DAC is a peptide commonly discussed in relation to growth hormone regulation and long-acting signaling pathways. It is part of a category of compounds designed to influence the release of endogenous growth hormone over an extended period.

Its structure and duration make it distinct from shorter-acting peptides used in similar contexts.

🧬 Mechanism of Action

CJC-1295 DAC is associated with prolonged stimulation of growth hormone release through interaction with:

growth hormone-releasing hormone (GHRH) pathways

pituitary signaling mechanisms

IGF-1 downstream activity

The “DAC” (Drug Affinity Complex) component allows it to remain active for a longer duration compared to non-DAC variants.

⏱️ DAC vs Non-DAC Variants

One of the key distinctions is between:

CJC-1295 DAC → longer half-life, sustained release

CJC-1295 (no DAC / Mod GRF 1-29) → shorter pulses, more frequent administration

This difference is often discussed when comparing long-term stability versus more controlled, pulse-based approaches.

⚖️ Comparison to Other GH-Related Compounds

CJC-1295 DAC is frequently mentioned alongside:

Ipamorelin

MK-677 (Ibutamoren)

recombinant HGH

Each interacts with the growth hormone axis differently, which is why understanding their roles is important when evaluating overall signaling effects.

📦 Structure and Peptide Context

To better understand how long-acting peptides like this are structured within the broader category, you can explore a CJC-1295 peptide overview for additional reference.

🧠 Final Notes

CJC-1295 DAC is primarily discussed for its extended activity and consistent signaling profile.

When viewed alongside shorter-acting peptides and other GH-related compounds, it helps illustrate how different approaches can influence the same biological pathway in distinct ways.

[mhmilon]

xdfyuighgd

https://medium.com/@vatari13/usa-election-2020-win-joe-biden-but-this-election-proves-just-how-racist-america-really-is-16df65357b46